Henry Schein Q4 EPS Estimate Reduced by Barrington Research

Henry Schein, Inc. (NASDAQ:HSIC) – Equities research analysts at Barrington Research lowered their Q4 2025 EPS estimates for Henry Schein in a report issued on Tuesday, May 6th. Barrington Research analyst M. Petusky now forecasts that the company will post earnings of $1.29 per share for the quarter, down from their previous forecast of $1.34. Barrington Research has a “Outperform” rating and a $86.00 price objective on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Barrington Research also issued estimates for Henry Schein’s Q1 2026 earnings at $1.17 EPS, Q2 2026 earnings at $1.25 EPS, Q3 2026 earnings at $1.35 EPS, Q4 2026 earnings at $1.44 EPS, FY2026 earnings at $5.20 EPS and FY2027 earnings at $5.60 EPS.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same period in the prior year, the business posted $1.10 EPS. Henry Schein’s quarterly revenue was down .1% compared to the same quarter last year.

A number of other equities analysts have also recently issued reports on the stock. StockNews.com cut shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Thursday, April 17th. Piper Sandler lowered their price target on Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research report on Wednesday, April 30th. Wells Fargo & Company dropped their price objective on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a report on Tuesday. UBS Group reduced their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 26th. Finally, Jefferies Financial Group raised their price target on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $79.30.

Henry Schein Stock Up 3.5 %

Shares of NASDAQ HSIC opened at $68.89 on Thursday. The firm’s fifty day moving average is $67.62 and its 200 day moving average is $71.46. Henry Schein has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The company has a market cap of $8.44 billion, a price-to-earnings ratio of 28.35, a PEG ratio of 2.13 and a beta of 0.87.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of HSIC. Versant Capital Management Inc raised its holdings in Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after acquiring an additional 335 shares during the last quarter. Investment Management Corp VA ADV bought a new stake in shares of Henry Schein in the 4th quarter worth $32,000. Rakuten Securities Inc. purchased a new position in shares of Henry Schein in the first quarter worth $34,000. Venturi Wealth Management LLC lifted its holdings in shares of Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after purchasing an additional 569 shares in the last quarter. Finally, Quent Capital LLC boosted its position in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after buying an additional 323 shares during the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now owns 62,688 shares in the company, valued at approximately $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is owned by company insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.